- Home
- RITR vs DRTS Comparison
RITR vs DRTS Comparison
Compare RITR & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RITR
- DRTS
- Stock Information
- Founded
- RITR 2015
- DRTS 2015
- Country
- RITR Hong Kong
- DRTS Israel
- Employees
- RITR N/A
- DRTS N/A
- Industry
- RITR
- DRTS Medical/Dental Instruments
- Sector
- RITR
- DRTS Health Care
- Exchange
- RITR NYSE
- DRTS Nasdaq
- Market Cap
- RITR 283.5M
- DRTS 274.0M
- IPO Year
- RITR 2024
- DRTS N/A
- Fundamental
- Price
- RITR $4.10
- DRTS $3.02
- Analyst Decision
- RITR
- DRTS Strong Buy
- Analyst Count
- RITR 0
- DRTS 2
- Target Price
- RITR N/A
- DRTS $8.00
- AVG Volume (30 Days)
- RITR 391.3K
- DRTS 40.1K
- Earning Date
- RITR 02-15-2025
- DRTS 08-13-2025
- Dividend Yield
- RITR N/A
- DRTS N/A
- EPS Growth
- RITR N/A
- DRTS N/A
- EPS
- RITR 0.09
- DRTS N/A
- Revenue
- RITR $47,948,887.00
- DRTS N/A
- Revenue This Year
- RITR N/A
- DRTS N/A
- Revenue Next Year
- RITR N/A
- DRTS N/A
- P/E Ratio
- RITR $49.35
- DRTS N/A
- Revenue Growth
- RITR 278.44
- DRTS N/A
- 52 Week Low
- RITR $2.24
- DRTS $1.93
- 52 Week High
- RITR $8.75
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- RITR N/A
- DRTS 48.72
- Support Level
- RITR N/A
- DRTS $2.95
- Resistance Level
- RITR N/A
- DRTS $3.07
- Average True Range (ATR)
- RITR 0.00
- DRTS 0.13
- MACD
- RITR 0.00
- DRTS -0.01
- Stochastic Oscillator
- RITR 0.00
- DRTS 33.72
About RITR REITAR LOGTECH HLDGS LTD
Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.